{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T22:10:03Z","timestamp":1745359803040,"version":"3.40.4"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1097\/anc.0b013e3182760f66","type":"journal-article","created":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T10:39:56Z","timestamp":1354012796000},"page":"369-370","source":"Crossref","is-referenced-by-count":1,"title":["Is Lasix After a Blood Transfusion Necessary?"],"prefix":"10.1097","volume":"12","author":[{"given":"Heather E.","family":"Elser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210316","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jpeds.2011.05.022","article-title":"Furosemide for packed red cell transfusion in preterm infants: a randomized controlled trial.","volume":"159","author":"Balegar","year":"2011","journal-title":"J Pediatr"},{"key":"R2-10-20210316","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/NPM-2008-00003","article-title":"Double-masked, randomized, placebo-controlled trial of furosemide after packed red blood cell transfusion in preterm infants.","volume":"1","author":"Sarkar","year":"2008","journal-title":"J Neonatal-Perinatal Med"},{"key":"R3-10-20210316","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0022-3476(88)80389-5","article-title":"Effect of booster blood transfusions on oxygen utilization in infants with bronchopulmonary dysplasia.","volume":"113","author":"Alverson","year":"1988","journal-title":"J Pediatr"},{"key":"R4-10-20210316","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0022-3476(05)80146-5","article-title":"Role of furosemide therapy after booster-packed erythrocyte transfusions in infants with bronchopulmonary dysplasia.","volume":"117","author":"Stefano","year":"1990","journal-title":"J Pediatr"},{"key":"R5-10-20210316","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1442-200X.2009.02886.x","article-title":"Exposure to furosemide as the strongest risk factor for nephrocalcinosis in preterm infants.","volume":"52","author":"Gimpel","year":"2010","journal-title":"Pediatr Int Off J Jpn Pediatr Soc"},{"key":"R6-10-20210316","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/adc.72.5.379","article-title":"Guidelines for the administration of blood products.","volume":"72","author":"Warwick","year":"1995","journal-title":"Arch Dis Child"},{"key":"R7-10-20210316","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00852850","article-title":"Salt and the newborn kidney.","volume":"5","author":"Haycock","year":"1991","journal-title":"Pediatr Nephrol"}],"container-title":["Advances in Neonatal Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00149525-201212000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T21:42:16Z","timestamp":1745358136000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00149525-201212000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":7,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/anc.0b013e3182760f66","relation":{},"ISSN":["1536-0903"],"issn-type":[{"type":"print","value":"1536-0903"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}